Equities

OptiBiotix Health PLC

OPTI:LSE

OptiBiotix Health PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)17.25
  • Today's Change-0.50 / -2.82%
  • Shares traded105.48k
  • 1 Year change72.50%
  • Beta1.7862
Data delayed at least 20 minutes, as of Apr 29 2024 14:42 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year OptiBiotix Health PLC's revenues fell -79.35% from 2.21m to 457.00k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 6.26m to 2.59m, a -58.68% decrease.
Gross margin49.31%
Net profit margin-1,911.88%
Operating margin1,656.51%
Return on assets-81.35%
Return on equity-85.62%
Return on investment-83.43%
More ▼

Cash flow in GBPView more

In 2022, cash reserves at OptiBiotix Health PLC fell by 955.00k. Cash Flow from Financing totalled 485.00k or 106.13% of revenues. In addition the company used 1.11m for operations while cash used for investing totalled 331.00k.
Cash flow per share-0.1468
Price/Cash flow per share--
Book value per share0.1029
Tangible book value per share0.0863
More ▼

Balance sheet in GBPView more

OptiBiotix Health PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio3.59
Quick ratio3.24
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.